Head-to-head · WeighScore
BiltRx vs Levers Health
The verdict
BiltRx takes it — 75.3/100 to 53.3/100.
BiltRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BiltRx is a US health-optimization telehealth platform spanning men's health, women's health, aesthetics and weight loss that offers compounded and brand-name GLP-1 medications.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | BiltRx | Levers Health |
|---|---|---|
| WeighScore | 75.3/100 | 53.3/100 |
| Grade | C | C |
| Scorecard rank | #57 | #468 |
| Semaglutide | $125/mo (all doses, compounded) | $247/mo (1.25 mg dose, compounded) |
| Tirzepatide | $129/mo (all doses, compounded) | $296/mo (5 mg dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #57 · C
Strengths
- Very low starting prices (semaglutide from 125 dollars, tirzepatide from 129 dollars)
- LegitScript verified and HIPAA compliant
- Names its 503A compounding pharmacies (Boothwyn and Southend)
- Offers both compounded and brand-name GLP-1 options
Where it loses points
- Covered states are behind a check-availability gate, not listed
- Starting prices may rise depending on plan and dose
Graded #468 · C
Strengths
- Named LLC entity
- Microdose GLP-1 option marketed for longevity
- Both semaglutide and tirzepatide available
Where it loses points
- No LegitScript or PCAB accreditation
- No physical address disclosed
- State availability not disclosed
- FAQ and terms pages return 404
- Above-average pricing ($247-$396/mo); tirzepatide any-dose plan is $396/mo (only the up-to-5mg low-dose plan is $296)
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.